FirsthandHealth
medRxiv PreprintsInternational17 November 2026

Pain-indicated buprenorphine prescribing in the United States, 2017-2025: national trends, state policy approaches, and payer patterns in a longitudinal ecological study

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

BackgroundBuprenorphine offers an analgesic option for selected adults with chronic pain. National trends in pain-indicated buprenorphine prescribing, variation across state policy approaches, and consistency within multiple insurance payers have not been examined together. We described national and state prescribing trends, compared growth among states with documented policies, and examined whether state patterns persisted among Medicaid recipients. MethodsLongitudinal ecological analysis of 2017-2025 prescription claims for 867,591 unique adults receiving transdermal or buccal buprenorphine
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.